Douglas L. Braunstein, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), bought 20,400 shares at $50.09 ($1.0M) on 2017-08-09, disclosed to the SEC on 2017-08-11.
Open-market purchase of $1.0M EGRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.06 | 3,610 | $173K | 17.3% |
| 2 | $49.21 | 15,206 | $748K | 74.7% |
| 3 | $50.09 | 1,584 | $79K | 7.9% |
| Total | $49.07 avg | 20,400 | $1.0M | 100% |
| Filing → |
| TALK | BUY | 2021-06-24 | $50.0M | — | Filing → |
| HCII | SELL | 2021-04-14 | $0 | — | Filing → |
| EGRX | SELL | 2019-10-15 | $984K | — | Filing → |